A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Jazz Pharmaceuticals
Merck Sharp & Dohme LLC
AstraZeneca
Taiho Oncology, Inc.
Arcus Biosciences, Inc.
Seagen Inc.
AstraZeneca
Hoffmann-La Roche
Jazz Pharmaceuticals
Merck Sharp & Dohme LLC
Eurofarma Laboratorios S.A.
Merck Sharp & Dohme LLC
Taiho Pharmaceutical Co., Ltd.
Innovent Biologics (Suzhou) Co. Ltd.
Merck Sharp & Dohme LLC
Boston Scientific Corporation
Merck Sharp & Dohme LLC
TG Therapeutics, Inc.
Valerio Therapeutics
Eli Lilly and Company
Sanofi
Sanofi
Chiron Corporation